Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery (COMPASS)


December 1, 2019

Clinical trial

Safety and Effectiveness of CyPass Supraciliary Micro-Stent in Primary Open-Angle Glaucoma: 5-Year Results from the COMPASS XT Study.

Reiss G, Clifford B, Vold S, He J, Hamilton C, Dickerson J, Lane S.

Am J Ophthalmol. 2019 Dec;208:219-225.
Full text | Metrics.

December 1, 2019

Clinical trial

Corneal Endothelial Cell Loss and Morphometric Changes 5 Years after Phacoemulsification with or without CyPass Micro-Stent.

Lass JH, Benetz BA, He J, Hamilton C, Von Tress M, Dickerson J, Lane S.

Am J Ophthalmol. 2019 Dec;208:211-218.
Full text | Metrics.

October 1, 2016

Clinical trial

Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts.

Vold S, Ahmed II, Craven ER, Mattox C, Stamper R, Packer M, Brown RH, Ianchulev T.

Ophthalmology. 2016 Oct;123(10):2103-12.
Full text | Metrics.

Share This Article :

Updated on March 7th, 2022

Source Archive